RECENT ANALYTICAL TRENDS IN TICAGRELOR QUANTIFICATION IN PHARMACEUTICAL AND BIOLOGICAL MATRICES: A SYSTEMATIC REVIEW
Authors: Chithra Devi S , KOKILAMBIGAI K S* AND MANIKANDAN K

ABSTRACT
Background: Ticagrelor is a direct-acting, reversible oral P2Y?? receptor antagonist widely prescribed for the prevention of thrombotic events in patients with acute coronary syndromes. Given its clinical relevance, accurate quantification in both pharmaceutical and biological matrices is essential for quality control, pharmacokinetic profiling, and bioequivalence studies. Objective: This review aims to systematically compile and evaluate the various analytical methods developed for the estimation of Ticagrelor, highlighting methodological advances, validation performance, and matrix-specific considerations. Methods: Peer-reviewed literature from 2014 to 2024 was collected using scientific databases such as PubMed, ScienceDirect, and Google Scholar. Studies employing techniques such as UV spectrophotometry, RP-HPLC, UPLC, HPTLC, and LC-MS/MS were reviewed and compared based on sample matrix, method sensitivity, linearity, and sample preparation approaches. Results: UV spectrophotometric methods offer simplicity and cost-effectiveness for routine analysis in bulk and dosage forms. RP-HPLC remains the most widely employed technique for tablet analysis due to its balance of precision, speed, and accessibility. In contrast, LC-MS/MS methods, especially those with triple quadrupole configurations, are preferred for plasmaanalysis owing to their high sensitivity, with LLOQs as low as 0.78 ng/mL. Several methods incorporated quality by design (QbD), green solvents, and stability-indicating capabilities. Conclusion: A diverse array of validated analytical techniques exists for Ticagrelor estimation, each suited for specific applications. However, opportunities remain for the development of faster, greener, and more automated methods for high-throughput analysis. This review offers a practical reference for researchers and analysts in pharmaceutical and clinical laboratories. Keywords: Ticagrelor, RP-HPLC, LC-MS/MS, UV spectrophotometry, Bioanalysis, Sample Preparation, Method Validation
Publication date: 01/07/2026
    https://www.ijbpas.com/pdf/2026/July/MS_IJBPAS_2026_10343.pdf
Download PDF
https://doi.org/10.31032/IJBPAS/2026/15.7.10343